Vioxx was withdrawn from the U.S. market in 2004. The manufacturer of Vioxx has announced a voluntary withdrawal of the drug from the U.S. and worldwide market.
Rofecoxib / ˌ r ɒ f ᵻ ˈ k ɒ k s ɪ b / is a nonsteroidal anti-inflammatory drug that has now been withdrawn over safety concerns. It was marketed by Merck & Co ...
Learn about the prescription medication Vioxx (Rofecoxib), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
Just a few years after the U.S. Food and Drug Administration (FDA) approved Vioxx, the drug was recalled because of the risk of deadly heart attacks and strokes.
As drugmakers scramble to grab Vioxx's multi-billion-dollar share of the arthritis and pain-relief market, patients might find themselves wondering whether ...
Merck & Co.’s arthritis drug Vioxx may have led to more than 27,000 heart attacks and sudden cardiac deaths before it was pulled from the market last week, the Wall ...
Vioxx Side Effects Lawsuits | Vioxx (Generic: Rofecoxib) from the market worldwide because new data from a clinical trial found an increased risk of heart attack and ...
Vioxx and Drug Safety. Statement of. Sandra Kweder, M.D. Deputy Director, Office of New Drugs Center for Drug Evaluation and Research U.S. Food and Drug ...
Once a leading prescription pain-relief medication worldwide, Vioxx (rofecoxib) and its manufacturer, Merck, fell from grace when scientists discovered the drug ...
Get information on the arthritis drug rofecoxib (Vioxx) removed from the US market by the manufacturer.